Latest immunotherapy news
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC
posted August 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors
posted August 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Personalized Vaccine Helped Melanoma Patients Stay Cancer-Free Longer, Drugmakers Say
posted August 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer
posted August 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Rituximab Noninferior to Ocrelizumab for Newly Diagnosed Relapsing MS Related Articles
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer 
Subset of Patients With Follicular Lymphoma Can Achieve Cure With CHOP-Based Chemoimmunotherapy 
Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer 
Guidelines Issued for Management of Acute Lymphoblastic Leukemia in Teens, Young Adults Monthly Specialist Briefings
Stay Connected
